{"title":"泛素特异性肽酶30介导叉头盒O3去泛素化通过调节cGAS/STING通路促进蛛网膜下腔出血的进展。","authors":"Guiqiang Zhang, Wenfeng Xu","doi":"10.1097/WNR.0000000000002192","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Subarachnoid hemorrhage (SAH) is a cerebrovascular disease with a very high disability and mortality rate, which brings a huge economic burden to society. It is reported that inhibition of forkhead box O3 (FOXO3) can alleviate brain edema and neuroinflammation after SAH. However, the role and mechanism of FOXO3 in regulating SAH progression need to be further studied.</p><p><strong>Methods: </strong>Mouse microglia were treated with oxyhemoglobin (OxyHb) to build SAH cell model in vitro. Western blot was used to measure the protein levels of FOXO3, ubiquitin-specific peptidase 30 (USP30), embryonic lethal-abnormal vision like protein 1 (ELAVL1), and pyroptosis-related proteins. Cell proliferation was tested by cell counting kit 8 assay and 5-ethynyl-2' -deoxyuridine assay. Inflammatory factors were detected by ELISA, and cell polarization was evaluated using flow cytometry. Cell pyroptosis was assessed by detecting. Co-immunoprecipitation assay, immunofluorescence colocalization assay, and RNA immunoprecipitation assay were used to evaluate the interaction between FOXO3 and USP30 or ELAVL1.</p><p><strong>Results: </strong>Downregulation of FOXO3 inhibited inflammation, M1 polarization, and pyroptosis in OxyHb-induced microglia. USP30 promoted FOXO3 expression through deubiquitination. USP30 knockdown suppressed inflammation, M1 polarization, and pyroptosis in OxyHb-induced microglia, and these effects were abolished by FOXO3 overexpression. Also, ELAVL1 interacted with FOXO3 to facilitate its mRNA stability. Meanwhile, USP30 increased FOXO3 expression to activate the cyclic GMP-AMP synthase (cGAS)/stimulator of interferon genes (STING) pathway.</p><p><strong>Conclusion: </strong>USP30-mediated deubiquitination of FOXO3 contributed to OxyHb-induced microglia inflammation, M1 polarization, and pyroptosis, providing a novel target for the treatment of SAH.</p>","PeriodicalId":19213,"journal":{"name":"Neuroreport","volume":"36 13","pages":"719-727"},"PeriodicalIF":1.7000,"publicationDate":"2025-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12316159/pdf/","citationCount":"0","resultStr":"{\"title\":\"Ubiquitin-specific peptidase 30-mediated deubiquitination of forkhead box O3 promotes the progression of subarachnoid hemorrhage by regulating cGAS/STING pathway.\",\"authors\":\"Guiqiang Zhang, Wenfeng Xu\",\"doi\":\"10.1097/WNR.0000000000002192\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Subarachnoid hemorrhage (SAH) is a cerebrovascular disease with a very high disability and mortality rate, which brings a huge economic burden to society. It is reported that inhibition of forkhead box O3 (FOXO3) can alleviate brain edema and neuroinflammation after SAH. However, the role and mechanism of FOXO3 in regulating SAH progression need to be further studied.</p><p><strong>Methods: </strong>Mouse microglia were treated with oxyhemoglobin (OxyHb) to build SAH cell model in vitro. Western blot was used to measure the protein levels of FOXO3, ubiquitin-specific peptidase 30 (USP30), embryonic lethal-abnormal vision like protein 1 (ELAVL1), and pyroptosis-related proteins. Cell proliferation was tested by cell counting kit 8 assay and 5-ethynyl-2' -deoxyuridine assay. Inflammatory factors were detected by ELISA, and cell polarization was evaluated using flow cytometry. Cell pyroptosis was assessed by detecting. Co-immunoprecipitation assay, immunofluorescence colocalization assay, and RNA immunoprecipitation assay were used to evaluate the interaction between FOXO3 and USP30 or ELAVL1.</p><p><strong>Results: </strong>Downregulation of FOXO3 inhibited inflammation, M1 polarization, and pyroptosis in OxyHb-induced microglia. USP30 promoted FOXO3 expression through deubiquitination. USP30 knockdown suppressed inflammation, M1 polarization, and pyroptosis in OxyHb-induced microglia, and these effects were abolished by FOXO3 overexpression. Also, ELAVL1 interacted with FOXO3 to facilitate its mRNA stability. Meanwhile, USP30 increased FOXO3 expression to activate the cyclic GMP-AMP synthase (cGAS)/stimulator of interferon genes (STING) pathway.</p><p><strong>Conclusion: </strong>USP30-mediated deubiquitination of FOXO3 contributed to OxyHb-induced microglia inflammation, M1 polarization, and pyroptosis, providing a novel target for the treatment of SAH.</p>\",\"PeriodicalId\":19213,\"journal\":{\"name\":\"Neuroreport\",\"volume\":\"36 13\",\"pages\":\"719-727\"},\"PeriodicalIF\":1.7000,\"publicationDate\":\"2025-09-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12316159/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Neuroreport\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1097/WNR.0000000000002192\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/7/11 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q4\",\"JCRName\":\"NEUROSCIENCES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neuroreport","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/WNR.0000000000002192","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/7/11 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
Ubiquitin-specific peptidase 30-mediated deubiquitination of forkhead box O3 promotes the progression of subarachnoid hemorrhage by regulating cGAS/STING pathway.
Background: Subarachnoid hemorrhage (SAH) is a cerebrovascular disease with a very high disability and mortality rate, which brings a huge economic burden to society. It is reported that inhibition of forkhead box O3 (FOXO3) can alleviate brain edema and neuroinflammation after SAH. However, the role and mechanism of FOXO3 in regulating SAH progression need to be further studied.
Methods: Mouse microglia were treated with oxyhemoglobin (OxyHb) to build SAH cell model in vitro. Western blot was used to measure the protein levels of FOXO3, ubiquitin-specific peptidase 30 (USP30), embryonic lethal-abnormal vision like protein 1 (ELAVL1), and pyroptosis-related proteins. Cell proliferation was tested by cell counting kit 8 assay and 5-ethynyl-2' -deoxyuridine assay. Inflammatory factors were detected by ELISA, and cell polarization was evaluated using flow cytometry. Cell pyroptosis was assessed by detecting. Co-immunoprecipitation assay, immunofluorescence colocalization assay, and RNA immunoprecipitation assay were used to evaluate the interaction between FOXO3 and USP30 or ELAVL1.
Results: Downregulation of FOXO3 inhibited inflammation, M1 polarization, and pyroptosis in OxyHb-induced microglia. USP30 promoted FOXO3 expression through deubiquitination. USP30 knockdown suppressed inflammation, M1 polarization, and pyroptosis in OxyHb-induced microglia, and these effects were abolished by FOXO3 overexpression. Also, ELAVL1 interacted with FOXO3 to facilitate its mRNA stability. Meanwhile, USP30 increased FOXO3 expression to activate the cyclic GMP-AMP synthase (cGAS)/stimulator of interferon genes (STING) pathway.
Conclusion: USP30-mediated deubiquitination of FOXO3 contributed to OxyHb-induced microglia inflammation, M1 polarization, and pyroptosis, providing a novel target for the treatment of SAH.
期刊介绍:
NeuroReport is a channel for rapid communication of new findings in neuroscience. It is a forum for the publication of short but complete reports of important studies that require very fast publication. Papers are accepted on the basis of the novelty of their finding, on their significance for neuroscience and on a clear need for rapid publication. Preliminary communications are not suitable for the Journal. Submitted articles undergo a preliminary review by the editor. Some articles may be returned to authors without further consideration. Those being considered for publication will undergo further assessment and peer-review by the editors and those invited to do so from a reviewer pool.
The core interest of the Journal is on studies that cast light on how the brain (and the whole of the nervous system) works.
We aim to give authors a decision on their submission within 2-5 weeks, and all accepted articles appear in the next issue to press.